Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity.
Bürk
K
K
Melms
A
A
Schulz
J B
JB
Dichgans
J
J
D000328:Adult; D000368:Aged; D002524:Cerebellar Ataxia / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D005903:Gliadin / Q000276:immunology; D005983:Glutens / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007413:Intestinal Mucosa / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D021182:Wheat Hypersensitivity / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology
D016756:Immunoglobulins, Intravenous; D005983:Glutens; D005903:Gliadin